Skip to main content

Advertisement

Log in

Fabrication and optimization of pH-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake

  • Original Article
  • Published:
Applied Nanoscience Aims and scope Submit manuscript

Abstract

Mannose receptors (MR) are highly over-expressed on macrophages in the inflammatory bowel disease (IBD) and can be targeted by developing mannose-anchored nano-carrier system. In this study, mannosylated chitosan (MC) polymer was synthesized because of its high affinity for mannose receptors. Afterward, MC nanoparticles (NPs) were fabricated encapsulating dexamethasone to target macrophages for attenuation of inflammation at initial stages. Further, NPs were coated with a pH-sensitive polymer to control the premature drug release in the stomach. NPs were optimized using a surface response quadratic model to study the impact of various process parameters. Optimized NPs were then characterized for size, morphology, zeta potential, surface chemistry, biocompatibility, and uptake by macrophages. The average particle size was found to be 380 ± 19.8 nm with an encapsulation efficiency of 78.1 ± 1.17%. pH-dependent drug release profile was obtained with an average release of 73.9 ± 5.24% over 72 h in simulated intestinal fluid (pH 7.4). Moreover, the NPs uptake by the macrophages supported the viability of macrophages with the NPs and did not show any adverse effects. Moreover, this study was supported by the uptake of NPs inside macrophages. Altogether, the data supported that MC NPs could serve as a potential anti-inflammatory therapeutic approach to target macrophages in IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

CD:

Crohn’s disease

DEXA:

Dexamethasone

DSC:

Differential scanning calorimetry

EE:

Encapsulation efficiency

ES100:

Poly (methacrylic acid-co-methyl methacrylate) 1:2, Eudragit® S100

FBS:

Fetal bovine serum

FTIR:

Fourier transform infrared spectroscopy

GIT:

Gastrointestinal tract

IBD:

Inflammatory bowel disease

IRFs:

Interferons

MC:

Mannosylated chitosan

MR:

Mannose receptor

NF-κB:

Nuclear factor-kappa activated B cells

NPs:

Nanoparticles

PAF:

Platelet activating factor

PAMPs:

Pathogen-associated molecular patterns

PDI:

Polydispersity index

PRRs:

Pattern recognition receptors

Rh-B:

Rhomadine B

SEM:

Scanning electron microscope

SGF:

Simulated gastric fluid

SIF:

Simulated intestinal fluid

TC:

Thiolated chitosan

TGA:

Thioglycolic acid

UC:

Ulcerative colitis

XPS:

X-ray photon spectroscopy

References

  • Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G (2019) Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. Nanomedicine 14:387–406

    Article  CAS  Google Scholar 

  • Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801

    Article  CAS  Google Scholar 

  • Ali H, Weigmann B, Neurath M, Collnot E, Windbergs M, Lehr C-M (2014) Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases. J Control Release 183:167–177

    Article  CAS  Google Scholar 

  • Ali H, Weigmann B, Collnot E-M, Khan SA, Windbergs M, Lehr C-M (2016) Budesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa—pharmaceutical characterization and fluorescence imaging. Pharm Res 33:1085–1092

    Article  CAS  Google Scholar 

  • Baer DR, Engelhard MH (2010) XPS analysis of nanostructured materials and biological surfaces. J Electron Spectrosc Relat Phenom 178:415–432

    Article  Google Scholar 

  • Beaugerie L, Langholz E, Nyboe-Andersen N, Pigneur B, Sokol H, Epicom E (2018) Differences in epidemiological features between ulcerative colitis and Crohn’s disease: the early life-programmed versus late dysbiosis hypothesis. Med Hypotheses 115:19–21

    Article  Google Scholar 

  • Bernkop-Schnürch A, Schwarz V, Steininger S (1999) Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res 16:876–881

    Article  Google Scholar 

  • Bruschi ML (2015) Mathematical models of drug release. Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing, Cambridge, p 63

    Google Scholar 

  • Chakraborty P, Ghosh D, Basu MK (2001) Modulation of macrophage mannose receptor affects the uptake of virulent and avirulent Leishmania donovani promastigotes. J Parasitol 87:1023–1027

    Article  CAS  Google Scholar 

  • Chaubey P, Mishra B (2014) Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohyd Polym 101:1101–1108

    Article  CAS  Google Scholar 

  • Chaubey P, Patel RR, Mishra B (2014) Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin Drug Deliv 11:1163–1181

    Article  CAS  Google Scholar 

  • Chawla A, Sharma P, Pawar P (2012) Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation. Acta Pharm 62:529–545

    Article  CAS  Google Scholar 

  • Davies M, Wilding I, Short R, Khan M, Watts J, Melia C (1989) An analysis of the surface chemical structure of polymethacrylate (Eudragit) film coating polymers by XPS. Int J Pharm 57:183–187

    Article  CAS  Google Scholar 

  • Dehshahri A, Oskuee RK, Ramezani M (2012) Plasmid DNA delivery into hepatocytes using a multifunctional nanocarrier based on sugar-conjugated polyethylenimine. Gene Ther Mol Biol 14:62–71

    Google Scholar 

  • Fu Y, Kao WJ (2010) Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 7:429–444

    Article  CAS  Google Scholar 

  • Giron F, Pastó A, Tasciotti E, Abraham BP (2019) Nanotechnology in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 25(12):1871–1880

    Article  Google Scholar 

  • Hatami E, Mu Y, Shields DN, Chauhan SC, Kumar S, Cory TJ, Yallapu MM (2019) Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting. Biochem Biophys Rep 17:197–207

    Google Scholar 

  • Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11:673–692

    Article  CAS  Google Scholar 

  • Hu D, Liu L, Chen W, Li S, Zhao Y (2012) A novel preparation method for 5-aminosalicylic acid loaded Eudragit S100 nanoparticles. Int J Mol Sci 13:6454–6468

    Article  CAS  Google Scholar 

  • ICH, I. G. Q3c (R6) (2016) on Impurities: guideline for residual solvents. International conference for harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH), Switzerland, 2016

  • Katta R, Deveswaran R, Bharath S, Basavaraj B (2017) Development of mesalazine microspheres for colon targeting. J Pharm Res 9:1–9

    Google Scholar 

  • Mazzarino L, Travelet C, Ortega-Murillo S, Otsuka I, Pignot-Paintrand I, Lemos-Senna E, Borsali R (2012) Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci 370:58–66

    Article  CAS  Google Scholar 

  • Mukhtar M, Ali H, Ahmed N, Munir R, Talib S, Khan AS, Ambrus R (2020) Drug delivery to macrophages: A review of nano-therapeutics targeted approach for inflammatory disorders and cancer. Expert Opin Drug Deliv. https://doi.org/10.1080/17425247.2020.1783237

    Article  Google Scholar 

  • Niu X, Zhang H, Li W, Mu Q, Yao H, Wang Y (2015) Anti-inflammatory effects of cavidine in vitro and in vivo, a selective COX-2 inhibitor in LPS-induced peritoneal macrophages of mouse. Inflammation 38:923–933

    Article  CAS  Google Scholar 

  • Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A (2007) 5-Amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. J Control Release 123:211–218

    Article  CAS  Google Scholar 

  • Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Rev Gastroenterol Hepatol 3:390

    Article  CAS  Google Scholar 

  • Shahnaz G, Edagwa BJ, McMillan J, Akhtar S, Raza A, Qureshi NA, Yasinzai M, Gendelman HE (2017) Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomedicine (Lond) 12:99–115

    Article  CAS  Google Scholar 

  • Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S (2007) Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm 67:211–219

    Article  CAS  Google Scholar 

  • Tams Todd RT (2003) Diseases of the stomach. In: Handbook of small animal gastroenterology. W B Saunders Company, pp 159–194

  • Thakral NK, Ray AR, Majumdar DK (2010) Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. J Mater Sci Mater Med 21:2691–2699

    Article  CAS  Google Scholar 

  • Tukulula M, Hayeshi R, Fonteh P, Meyer D, Ndamase A, Madziva MT, Khumalo V, Lubuschagne P, Naicker B, Swai H (2015) Curdlan-conjugated PLGA nanoparticles possess macrophage stimulant activity and drug delivery capabilities. Pharm Res 32:2713–2726

    Article  CAS  Google Scholar 

  • Vafaei SY, Esmaeili M, Amini M, Atyabi F, Ostad SN, Dinarvand R (2016) Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa. Carbohyd Polym 144:371–381

    Article  CAS  Google Scholar 

  • Weissleder R, Nahrendorf M, Pittet MJ (2014) Imaging macrophages with nanoparticles. Nat Mater 13:125

    Article  CAS  Google Scholar 

  • Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L (2018) Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. Int J Biol Macromol 113:534–542

    Article  CAS  Google Scholar 

  • Yang W, Fu J, Wang T, He N (2009) Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J Biomed Nanotechnol 5:591–595

    Article  CAS  Google Scholar 

  • Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B (2019a) Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm 558:201–214

    Article  CAS  Google Scholar 

  • Zeeshan M, Ali H, Khan S, Mukhtar M, Khan MI, Arshad M (2019b) Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Nanomedicine 14:1945–1969

    Article  CAS  Google Scholar 

  • Zhang DL, Deng YF, Li CB, Chen J (2008) Separation of ethyl acetate− ethanol azeotropic mixture using hydrophilic ionic liquids. Ind Eng Chem Res 47:1995–2001

    Article  CAS  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hussain Ali.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukhtar, M., Zesshan, M., Khan, S. et al. Fabrication and optimization of pH-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake. Appl Nanosci 10, 4013–4027 (2020). https://doi.org/10.1007/s13204-020-01510-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13204-020-01510-y

Keywords

Navigation